Adverse Drug Events: Database Construction and in Silico Prediction
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Adverse drug events (ADEs) are the harms associated with uses of given medications at normal dosages, which are crucial for a drug to be approved in clinical use or continue to stay on the market. Many ADEs are not identified in trials until the drug is approved for clinical use, which results in adverse morbidity and mortality. To date, millions of ADEs have been reported around the world. Methods to avoid or reduce ADEs are an important issue for drug discovery and development. Here, we reported a comprehensive database of adverse drug events (namely MetaADEDB), which included more than 520,000 drug-ADE associations among 3059 unique compounds (including 1330 drugs) and 13,200 ADE items by data integration and text mining. All compounds and ADEs were annotated with the most commonly used concepts defined in Medical Subject Headings (MeSH). Meanwhile, a computational method, namely the phenotypic network inference model (PNIM), was developed for prediction of potential ADEs based on the database. The area under the receive operating characteristic curve (AUC) is more than 0.9 by 10-fold cross validation, while the AUC value was 0.912 for an external validation set extracted from the US-FDA Adverse Events Reporting System, which indicated that the prediction capability of the method was reliable. MetaADEDB is accessible free of charge at http://www.lmmd.org/online_services/metaadedb/. The database and the method provide us a useful tool to search for known side effects or predict potential side effects for a given drug or compound.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of publicly available ADE databases exist, which have been constructed by extracting, stratifying or detecting signals from a variety of sources, including drug labels, electronic health records, research literature, social media, and adverse event reporting pharmacovigilance programs7–11.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [9]
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
The unified medical language system (UMLS): integrating biomedical terminology
Bodenreider, O. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh061 · Cited by 4,356
admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties
Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300367a · Cited by 2,222
Self-citationDrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936
Quantitative signal detection using spontaneous ADR reporting
Bate, A., & Evans, S. J. W. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1742 · Cited by 912
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 818
Self-citationMcKusick's Online Mendelian Inheritance in Man (OMIM(R))
Amberger, J., Bocchini, C. A., Scott, A. F., & Hamosh, A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn665 · Cited by 717
Szarfman, A., Machado, S. G., & O??Neill, R. T. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00001 · Cited by 700
Research works printed but not linked: 2
- Harpaz R., 2011, Clin. Pharmacol. Ther., 89, 243, 10.1038/clpt.2010.285 · DOI
- Boyle N. M, 2011, J. Cheminf., 3
Cited by
Cheng, F., & Zhao, Z. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002512 · Cited by 374
“28 In this study, we built a more comprehensive drug – ADR network by integrating data from MetaADEDB and the FDA Adverse Events Reporting System (FAERS) created by the US Food and Drug Administration (US FDA).”
MethodSelf-citationTarget identification among known drugs by deep learning from heterogeneous networks
Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357
Self-citationYang, H., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00030 · Cited by 280
“In a previous paper published in 2013, we reviewed the advances and challenges of in silico prediction of chemical toxicity together with pharmacokinetic properties (Cheng et al., 2013a).”
BackgroundMethodSelf-citationNetwork-Based Methods for Prediction of Drug-Target Interactions
Wu, Z., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01134 · Cited by 237
“Then, drug-gene-disease networks were constructed for two example GPCR drugs named clemastine and dobutamine, by integrating the known and predicted DTIs as well as side-effect data from MetaADEDB (Cheng et al., 2013b) and Lounkine’s study (Lounkine et al., 2012).”
MethodSelf-citationComputational network biology: Data, models, and applications
Liu, C., Ma, Y., Zhao, J., Nussinov, R., Zhang, Y.-C., Cheng, F., & Zhang, Z.-K. (2020) · Physics Reports · doi:10.1016/j.physrep.2019.12.004 · Cited by 227
Self-citationDing, Y., Tang, J., & Guo, F. (2019) · Neurocomputing · doi:10.1016/j.neucom.2018.10.028 · Cited by 221
Application of text mining in the biomedical domain
Fleuren, W. W. M., & Alkema, W. (2015) · Methods · doi:10.1016/j.ymeth.2015.01.015 · Cited by 193
Predicting drug side effects by multi-label learning and ensemble learning
Zhang, W., Liu, F., Luo, L., & Zhang, J. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0774-y · Cited by 187
“To the best of our knowledge, some state-of-the-art methods, i.e. Pauwels ’ s method [7], Mizutani ’ s method [8], Liu ’ s method [10] and Cheng ’ s method [12], were proposed for side effect prediction, and their source codes or datasets are publicly available.”
MethodComputational prediction of drug-drug interactions based on drugs functional similarities
Ferdousi, R., Safdari, R., & Omidi, Y. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.04.021 · Cited by 192
Chowdhury, P. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1803968 · Cited by 163
“Variety of simulation methods and databases have yet been used for the in-silico prediction of target drugs (Cheng et al., 2013; Figure 1.”
MethodPredicting potential side effects of drugs by recommender methods and ensemble learning
Zhang, W., Zou, H., Luo, L., Liu, Q., Wu, W., & Xiao, W. (2015) · Neurocomputing · doi:10.1016/j.neucom.2015.08.054 · Cited by 154
Wu, Z., Cheng, F., Li, J., Li, W., Liu, G., & Tang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw012 · Cited by 143
Self-citationTransfer and Multi-task Learning in QSAR Modeling: Advances and Challenges
Simões, R. S., Maltarollo, V. G., Oliveira, P. R., & Honorio, K. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00074 · Cited by 116
“Analyses on multi-label classification showed that the proposed transfer learning approaches achieved better performance than state-of-art-methods (Pauwels et al., 2011; Liu et al., 2012; Cheng et al., 2013) applied to benchmark datasets.”
MethodIn silico methods to predict drug toxicity
Roncaglioni, A., Toropov, A. A., Toropova, A. P., & Benfenati, E. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.001 · Cited by 121
Davis, A. P., Wiegers, T. C., Roberts, P. M., King, B. L., Lay, J. M., Lennon-Hopkins, K., Sciaky, D., Johnson, R., Keating, H., Greene, N., et al. (2013) · Database · doi:10.1093/database/bat080 · Cited by 107
“In fact, curation from this project has already been incorporated into MetaADEDB, a new database of adverse drug events (30,31).”
MethodIdentification of Drug-Side Effect Association via Semisupervised Model and Multiple Kernel Learning
Ding, Y., Tang, J., & Guo, F. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2883834 · Cited by 113
“[11] constructed a phenotypic network inference model (PNIM) to identify nevol drug-side effect associations.”
MethodThe impact of in silico screening in the discovery of novel and safer drug candidates
Rognan, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.034 · Cited by 119
Computational methods for drug design and discovery: focus on China
Zheng, M., Liu, X., Xu, Y., Li, H., Luo, C., & Jiang, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.004 · Cited by 116
“Recently, Cheng et al. reported a database of adverse drug events (ADEs) named MetaADEDB, collected by data integration and text mining [74,75].”
BackgroundIn silico Prediction of Drug Induced Liver Toxicity Using Substructure Pattern Recognition Method
Zhang, C., Cheng, F., Li, W., Liu, G., Lee, P. W., & Tang, Y. (2016) · Molecular Informatics · doi:10.1002/minf.201500055 · Cited by 111
Self-citationCheng, F., Li, W., Wu, Z., Wang, X., Zhang, C., Li, J., Liu, G., & Tang, Y. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400010x · Cited by 113
Self-citationNetwork Pharmacology: Exploring the Resources and Methodologies
Junaid, M., Khan, A., Ali, A., Fang, L., Yanjing, W., Xu, Q., & Wei, D. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180330141351 · Cited by 105
Feature-derived graph regularized matrix factorization for predicting drug side effects
Zhang, W., Liu, X., Chen, Y., Wu, W., Wang, W., & Li, X. (2018) · Neurocomputing · doi:10.1016/j.neucom.2018.01.085 · Cited by 101
Zhang, W., Yue, X., Huang, F. F., Liu, R., Chen, Y., & Ruan, C. (2018) · Methods · doi:10.1016/j.ymeth.2018.06.001 · Cited by 94
Park, K., Kim, D., Ha, S., & Lee, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140816 · Cited by 102
Metabolic Network Prediction of Drug Side Effects
Shaked, I., Oberhardt, M., Atias, N., Sharan, R., & Ruppin, E. (2016) · Cell Systems · doi:10.1016/j.cels.2016.03.001 · Cited by 101
“Several other computational methods have emerged recently to address this need (see, e.g., Cheng et al., 2013).”
MethodCheng, F., Hong, H., Yang, S., & Wei, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw051 · Cited by 99
Self-citationLi, J., Lei, K., Wu, Z., Li, W., Liu, G., Liu, J., Cheng, F., & Tang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10052 · Cited by 97
Self-citationPredicting CircRNA-Disease Associations Through Linear Neighborhood Label Propagation Method
Zhang, W., Yu, C., Wang, X., & Liu, F. (2019) · IEEE Access · doi:10.1109/access.2019.2920942 · Cited by 83
Self-citationFang, J., Wu, Z., Cai, C., Wang, Q., Tang, Y., & Cheng, F. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00216 · Cited by 92
Self-citationDrug side effect prediction through linear neighborhoods and multiple data source integration
Zhang, W., Chen, Y., Tu, S., Liu, F., & Qu, Q. (2016) · 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2016.7822555 · Cited by 70
A unified frame of predicting side effects of drugs by using linear neighborhood similarity
Zhang, W., Yue, X., Liu, F., Chen, Y., Tu, S., & Zhang, X. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0477-2 · Cited by 68
“However, these benchmark methods are usually designed for either SEND task [13, 14, 18] or SEAD task [19, 20]; only on method: Liu ’ s method is suitable for both tasks.”
MethodInfluentialIn Silico Oncology Drug Repositioning and Polypharmacology
Cheng, F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8868-6_15 · Cited by 62
Self-citationWu, Z., Peng, Y., Yu, Z., Li, W., Liu, G., & Tang, Y. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00291 · Cited by 61
Self-citationCai, C., Fang, J., Guo, P., Wang, Q., Hong, H., Moslehi, J. J., & Cheng, F. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00641 · Cited by 52
Self-citationPredicting Drug Side Effects Using Data Analytics and the Integration of Multiple Data Sources
Lee, W., Huang, J.-Y., Chang, H., Lee, K., & Lai, C.-T. (2017) · IEEE Access · doi:10.1109/access.2017.2755045 · Cited by 58
“For example, Cheng et al. [24] plotted drugs, side effect terms and the known side effects on a bipartite graph.”
BackgroundSurvey of Similarity-Based Prediction of Drug-Protein Interactions
Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 52
Boyce, R. D., Ryan, P. B., Norén, G. N., Schuemie, M. J., Reich, C., Duke, J., Tatonetti, N. P., Trifirò, G., Harpaz, R., Overhage, J. M., et al. (2014) · Drug Safety · doi:10.1007/s40264-014-0189-0 · Cited by 49
“…using metabolic pathways extracted from the scientific literature, models that infer adverse events from graphical models of drug and conditions [40–42], and methods that use innovative approaches to overcome known limitations of drug safety sources such as spontaneous adverse event reports [18]…”
MethodPredicting drug-disease associations based on the known association bipartite network
Zhang, W., Yue, X., Chen, Y., Lin, W., Li, B., Liu, F., & Li, X. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217698 · Cited by 49
“The resource allocation method is a popular method for predicting unobserved links in the bipartite network, and has been successfully applied to lots of problems [14, 15, 21, 28].”
BackgroundMethodLü, W., Cheng, F., Jiang, J., Zhang, C., Deng, X., Xu, Z., Zou, S., Shen, X., Tang, Y., & Huang, J. Y. (2015) · Scientific Reports · doi:10.1038/srep08114 · Cited by 48
Self-citationLarge-Scale Prediction of Drug-Target Interaction: a Data-Centric Review
Cheng, T., Hao, M., Takeda, T., Bryant, S. H., & Wang, Y. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0092-6 · Cited by 53
Wang, T., Wu, Z., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00668 · Cited by 46
“…systems pharmacology/toxicology approaches to investigate the molecular mechanisms of therapeutic effects of known drugs or active compounds, and side effects of known drugs or environmental compounds (Cheng et al., 2013a,b; Li H. et al., 2014; Li et al., 2016; Lu et al., 2015; Wang et al., 2017).”
BackgroundSelf-citationApplication of machine learning in drug side effect prediction: databases, methods, and challenges
Zhao, H., Zhong, J., Liang, X., Xie, C., & Wang, S. (2024) · Frontiers of Computer Science · doi:10.1007/s11704-024-31063-0 · Cited by 51
Koutroumpa, N.-M., Papavasileiou, K. D., Papadiamantis, A. G., Melagraki, G., & Afantitis, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076573 · Cited by 47
“MetaADEBD [94], CTD [95], SIDER [96], and OFF-SIDES [97] are databases containing information on drugs and adverse effects, and were used in [74] to design the drug–side effect network.”
MethodZhou, H., Cao, H., Matyunina, L., Shelby, M., Cassels, L., McDonald, J. F., & Skolnick, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01248 · Cited by 39
“Because the methods by Zhang et al. 12 and Cheng et al. 15 were designed to predict missing or undetected side e ff ects of known drugs with annotated side e ff ects and MEDICASCY aims to predict side e ff ects for drugs without a priori knowledge of their side e ff ects, it is not appropriate to compare MEDICASCY to them.”
MethodCao, D., Xiao, N., Li, Y., Zeng, W., Liang, Y., Lu, A., Xu, Q., & Af, C. (2015) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12002 · Cited by 43
“10 These two methods only utilize a part of the network structure information, and neglect drug or ADR intrinsic properties.”
MethodRouse, R. L., Kruhlak, N. L., Weaver, J. L., Burkhart, K., Patel, V. P., & Strauss, D. G. (2017) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479017720249 · Cited by 40
Network-Based Methods and Their Applications in Drug Discovery
Yu, Z., Wu, Z., Wang, Z., Wang, Y., Zhou, M., Li, W., Liu, G., & Tang, Y. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01613 · Cited by 38
Self-citationBig Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials
Federer, C., Yoo, M., & Tan, A. C. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.742 · Cited by 43
“Currently, this database contains 1,332 drugs, 10,097 AEs, and 438,801 drug-AE pairs, and these information could be used for polypharmacology research.10 MetaADEDB is a database of adverse drug events and has been recently developed by combining SIDER, OFFSIDES, and the Comparative Toxicology Database.11 Machine lear…”
Accurate and transferable drug–target interaction prediction with DrugLAMP
Luo, Z., Wu, W., Sun, Q., & Wang, J. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae693 · Cited by 44
collaborative, T. K. B. W. O. T. O. H. D. S. A. I. (., Boyce, R. D., Voss, E. A., Huser, V., Evans, L., Reich, C., Duke, J. D., Tatonetti, N. P., Lorberbaum, T., Dumontier, M., et al. (2017) · Journal of Biomedical Semantics · doi:10.1186/s13326-017-0115-3 · Cited by 37
“Existing frameworks that have integrated various sources in a way that provide some of these features include ADEPedia [13, 14], MetaADEDB [15], CATTLE [16], and Bio2RDF [17].”
BackgroundIdentification of Drug–Side-Effect Association via Multiview Semisupervised Sparse Model
Ding, Y., Guo, F., Tiwari, P., & Zou, Q. (2023) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2023.3314405 · Cited by 35
“Our results demonstrate that Mv3SM outperforms several existing methods, including Cheng’s method [9], the ensemble model [6], NRLMF [13], CMF [10], GRMF [11], RBMBM [6], INBM [6], Liu’s method [8], Pauwels’s method [5], Mizutani’s method [7], and NDDSA [49].”
BackgroundMethodXue, R., Liao, J., Shao, X., Han, K., Long, J., Shao, L., Ai, N., & Fan, X. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00238 · Cited by 33
Zhang, C., Hong, H., Mendrick, D. L., Tang, Y., & Cheng, F. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.81 · Cited by 34
Self-citationHuang, F. F., Qiu, Y., Li, Q., Liu, S., & Ni, F. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00218 · Cited by 31
“Cheng et al. (2013) adopted a resource allocation-based approach to infer unobserved side effects for existing drugs.”
Guo, X., Zhou, W., Yu, Y., Ding, Y., Tang, J., & Guo, F. (2020) · BioMed Research International · doi:10.1155/2020/4675395 · Cited by 33
“Cheng and Wang proposed the Phenotypic Network Inference Model (PNIM) [23] to detect new potential drug-side e ff ect associations.”
BackgroundIntSide: a web server for the chemical and biological examination of drug side effects
Juan-Blanco, T., Duran‐Frigola, M., & Aloy, P. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu688 · Cited by 33
Wu, Z., Lü, W., Yu, W., Wang, T., Li, W., Liu, G., Zhang, H., Pang, X., Huang, J. Y., Liu, M., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.005 · Cited by 31
Self-citationAn Ensembled SVM Based Approach for Predicting Adverse Drug Reactions
Joshi, P., Masilamani, V., & Ramesh, R. (2020) · Current Bioinformatics · doi:10.2174/1574893615999200707141420 · Cited by 38
Optimizing drug development in oncology by clinical trial simulation: Why and how?
Gal, J., Milano, G. A., Ferrero, J.-M., Saâda-Bouzid, E., Viotti, J., Chabaud, S., Gougis, P., Tourneau, C. L., Schiappa, R., Paquet, A. C., et al. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx055 · Cited by 34
“Two important computational tools in preclinical studies were published recently [76, 173].”
Identification of drug-side effect association via restricted Boltzmann machines with penalized term
Qian, Y., Ding, Y., Zou, Q., & Guo, F. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac458 · Cited by 27
ChemBioSim: Enhancing Conformal Prediction of In Vivo Toxicity by Use of Predicted Bioactivities
de Lomana, M. G., Morger, A., Norinder, U., Buesen, R., Landsiedel, R., Volkamer, A., Kirchmair, J., & Mathea, M. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00451 · Cited by 25
Drug-induced diabetes type 2: In silico study involving class B GPCRs
Latek, D., Rutkowska, E. E., Niewieczerzał, S., & Cielecka‐Piontek, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208892 · Cited by 28
“Pharmacophore modeling, QSAR studies, ADME/ADME-Tox properties prediction and other in-silico methods for SAR (structure-activity relationship) determination are standard approaches to improve drug selectivity not only for the sake of its efficacy but also to reduce its off-target or toxic effects [21, 22].”
MethodSari, A. N., Elwakeel, A., Dhanjal, J. K., Kumar, V., Sundar, D., Kaul, S. C., & Wadhwa, R. (2021) · Cancers · doi:10.3390/cancers13040835 · Cited by 29
Legehar, A., Xhaard, H., & Ghemtio, L. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0141-7 · Cited by 25
“In another recent study, Cheng and coworkers developed a meta-database of drug adverse effects, MetaADEDB, which includes the SIDER data [32].”
BackgroundsNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides
Luo, H., Ye, H., Ng, H. W., Sakkiah, S., Mendrick, D. L., & Hong, H. (2016) · Scientific Reports · doi:10.1038/srep32115 · Cited by 24
Biomarkers: Delivering on the expectation of molecularly driven, quantitative health
Wilson, J. L., & Altman, R. B. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217744775 · Cited by 27
“A combined database (MetaADEDB) and drug side effect similarity inference method identified drug-binding partners mediating off-target effects for antiasthma and anti-depression medications.(54,55) Network modeling using protein– protein interactions uncovered mediators of drug-induced rhabdomyolysis,(56) drug-induced…”
MethodIn silico profiling of systemic effects of drugs to predict unexpected interactions
Yoo, S., Noh, K., Shin, M., Park, J., Lee, K.-H., Nam, H., & Lee, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-19614-5 · Cited by 23
“Detailed information of enriched phenotypes of four high-scored clusters can be found in Supplementary Tables 2–5.”
BackgroundNatsiavas, P., Malousi, A., Cédric Bousquet, B., Jaulent, M., & Koutkias, V. G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00415 · Cited by 23
“…et al., 2014; Iyer et al., 2014) • Monitoring (Marcos et al., 2013) ADE databases • Signal detection (Huang et al., 2011; Gurulingappa et al., 2012; Cheng et al., 2013; Cheng and Zhao, 2014; Iyer et al., 2014; Shang et al., 2014; Cai et al., 2015; Herrero-Zazo et al., 2015; Jiang et al., 2015;…”
BackgroundMethodInfluentialNDDSA: A network- and domain-based method for predicting drug-side effect associations
Shabani-Mashcool, S., Marashi, S., & Gharaghani, S. (2020) · Information Processing & Management · doi:10.1016/j.ipm.2020.102357 · Cited by 24
Quantitative prediction of drug side effects based on drug-related features
Niu, Y., & Zhang, W. (2017) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-017-0236-5 · Cited by 23
“Cheng [17] proposed a phenotypic network inference-based method to predict drug side effects.”
Improving drug safety with a systems pharmacology approach
Schotland, P., Bojunga, N., Zien, A., Trame, M. N., & Lesko, L. J. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.06.009 · Cited by 20
Schotland, P., Racz, R., Jackson, D., Levin, R. L., Strauss, D. G., & Burkhart, K. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12356 · Cited by 19
Yu, L., Xu, Z., Qiu, W., & Xiao, X. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107812 · Cited by 21
Low, Y., Sedykh, A., Rusyn, I., & Tropsha, A. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140506121116 · Cited by 20
“Associations successfully predicted in recent studies include those of phenotype-target [72], chemical-phenotype [76,77], and chemicaltarget [74,78,79] type.”
ResultTanaka, Y., Chen, H. Y., Belloni, P., Gisladottir, U., Kefeli, J., Patterson, J., Srinivasan, A., Zietz, M., Sirdeshmukh, G., Berkowitz, J., et al. (2025) · Med · doi:10.1016/j.medj.2025.100642 · Cited by 17
Fruits as nutraceuticals: A review of the main fruits included in nutraceutical patents
Mesa, N. C., Alves, I. A., Vilela, F. M. P., Silva, D. M. E., Palomeque-Forero, L. A., Aragón, D. M., & da Costa, J. D. C. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113013 · Cited by 17
MetaADEDB 2.0: a comprehensive database on adverse drug events
Yu, Z., Wu, Z., Li, W., Liu, G., & Tang, Y. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa973 · Cited by 17
Self-citationWang, J., Wu, Z., Peng, Y., Li, W., Liu, G., & Tang, Y. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00009 · Cited by 18
Self-citationRapid Assessment of Adverse Drug Reactions by Statistical Solution of Gene Association Network
Xiang, Y., Liu, K., Cheng, X., Cheng, C., Gong, F., Pan, J., & Ji, Z. (2014) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2014.2338292 · Cited by 17
“The drug-gene relations were derived from CTD as well as literature, and the drug-ADR relations were derived from DailyMed, SIDER2, and MetaADEDB.”
BackgroundMethodInfluentialExploring adverse drug events at the class level
Winnenburg, R., Sorbello, A. F., & Bodenreider, O. (2015) · Journal of Biomedical Semantics · doi:10.1186/s13326-015-0017-1 · Cited by 15
“Researchers have also created repositories of ADEs, such ADEpedia [14] and used network analysis to analyze and predict drug-ADE associations [15].”
Qian, Y., Wang, Y., Liu, J., Zou, Q., Ding, Y., Guo, X., & Ding, W. (2024) · Information Fusion · doi:10.1016/j.inffus.2024.102894 · Cited by 15
DSEP: A Tool Implementing Novel Method to Predict Side Effects of Drugs
Niu, S.-Y., Xin, M.-Y., Luo, J., Liu, M., & Jiang, Z. (2015) · Journal of Computational Biology · doi:10.1089/cmb.2015.0129 · Cited by 16
“Some tools or databases have been constructed to predict or inquire drug–ADR associations (for instance, Cheng et al., 2013; Juan et al., 2015).”
Ji, X., Wang, L., Hua, L., Wang, X., Zhang, P., Shendre, A., Feng, W., Li, J., & Li, L. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2928305 · Cited by 14
“…for the prediction of ADEs using a database named MetaADEDB which includes 1,330 drugs, 13,200 ADEs, and more than 520,000 drug-ADE associations [24], and also developed a drug side effect similarity inference method (DSESI) for prediction of drug-target interaction using the same database [25].”
MethodSelf-citationADENet: a novel network-based inference method for prediction of drug adverse events
Yu, Z., Wu, Z., Li, W., Liu, G., & Tang, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab580 · Cited by 14
Self-citationJi, X., Cui, G., Xu, C., Hou, J., Zhang, Y., & Ren, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.773135 · Cited by 16
“…been used to detect ADEs using SRSs; some network-based methods and machine learning algorithms have been developed to predict ADEs using different public databases (Cami, et al., 2011; Liu, et al., 2012; Cheng, et al., 2013; Lin, et al., 2013; Davazdahemami and Delen, 2018; Jamal, et al., 2019).”
MethodBi, X., Ma, H., Li, J., Ma, Y., & Chen, D. (2018) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-018-0960-7 · Cited by 14
“If an ADE is associated with a given drug in MetaADEDB, the corresponding bit is set to 1; otherwise 0.”
InfluentialDing, Y., Zhou, H., Zou, Q., & Yuan, L. (2023) · Methods · doi:10.1016/j.ymeth.2023.09.008 · Cited by 12
Literature based discovery of alternative TCM medicine for adverse reactions to depression drugs
Xie, Q. S., Yang, K. M., Heo, G. E., & Song, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03735-8 · Cited by 12
The optimization of combinatorial drug therapies: Strategies and laboratorial platforms
Wang, B., Warden, A. R., & Ding, X. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.023 · Cited by 11
Prediction of Drug-Drug Interactions Using Pharmacological Similarities of Drugs
Çelebi, R., Mostafapour, V., Yasar, E., Gümüş, Ö., & Dikenelli, O. (2015) · International Workshop on Database and Expert Systems Applications (DEXA) · doi:10.1109/dexa.2015.23 · Cited by 11
“We also integrated MetaADEDB [25] dataset to Drugbank dataset to calculate phenotypic similarity.”
MethodInsights into the Molecular Mechanisms of Liuwei Dihuang Decoction via Network Pharmacology
Chen, J., Teng, D., Wu, Z., Li, W., Feng, Y., Tang, Y., & Liu, G. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00359 · Cited by 11
Self-citationImproving the Prediction of Adverse Drug Events Using Feature Fusion-Based Predictive Network Models
Li, J., Ji, X., & Hua, L. (2020) · IEEE Access · doi:10.1109/access.2020.2979452 · Cited by 10
“Cheng et al. published a drug side-effect similarity inference (DSESI) to predict the drug– target interaction with 621 drugs and 893 targets based on the drug side-effect database known as MetaADEDB, which included 1,330 drugs, 13,200 ADEs, and more than 520,000 drug-ADE associations [13].”
BackgroundHUME: large-scale detection of causal genetic factors of adverse drug reactions
Mansouri, M., Yuan, B., Ross, C. J., Carleton, B., & Ester, M. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty475 · Cited by 8
A hierarchical anatomical classification schema for prediction of phenotypic side effects
Wadhwa, S., Gupta, A., Dokania, S., Kanji, R., & Bagler, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193959 · Cited by 9
Polypharmacology and Natural Products
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_15 · Cited by 7
A Drug Similarity-Based Bayesian Method for Early Adverse Drug Event Detection
Shi, Y., Yang, Y., Liu, R., Sun, A., Peng, X., Li, L., Zhang, P., & Zhang, P. (2025) · Drug Safety · doi:10.1007/s40264-025-01545-6 · Cited by 7
“Besides chemical structures, drug similarity networks can also be derived from drug-targeted genes, proteins, and pathways [11].”
Transforming Healthcare: The Role of Generative AI in Personalized Treatment Recommendations
Gupta, V., Singh, A., Singh, H., & Chaudhary, E. (2024) · Advances in Healthcare Information Systems and Administration · doi:10.4018/979-8-3693-7452-8.ch011 · Cited by 5
Prinz, J., Koohi‐Moghadam, M., Sun, H., Kocher, J.-P. A., & Wang, J. (2018) · Human Heredity · doi:10.1159/000492574 · Cited by 5
“Besides, polypharmacological profiles of drugs as well as drug-drug interactions have been successfully predicted by jointly investigating the chemical, side effect, and therapeutic similarity of drugs in a network-based approach [16–18].”
BackgroundRelating Substructures and Side Effects of Drugs with Chemical-chemical Interactions
Zhou, B., Zhao, X., Lu, J., Sun, Z., Liu, M., Zhou, Y., Liu, R., & Wang, Y. (2019) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207322666190702102752 · Cited by 5
Self-citationYu, Z., Wu, Z., Zhou, M., Chen, L., Li, W., Liu, G., & Tang, Y. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107831 · Cited by 5
Self-citation
Metadata
- Authors
- Cheng, F., Li, W., Wang, X., Zhou, Y., Wu, Z., Shen, J., & Tang, Y.
- Affiliations
- East China University of Science and Technology (CN)
- Second Military Medical University (CN)
- Corresponding author
- Tang, Yun
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-04-08
- Volume
- 53
- Issue
- 4
- Pages
- 744-752
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2031133736
- Cited by
- 124
- References
- 39
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 13 · 2019: 13 · 2018: 20 · 2017: 16 · 2016: 11 · 2015: 11 · 2014: 6 · 2013: 4
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Chemical Information and Modeling (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- adverse drug reactions, drug side effect prediction, text mining, drug safety, FDA Adverse Event Reporting System, in silico prediction
- MeSH terms
- Algorithms, Computer Simulation, Humans, Predictive Value of Tests, ROC Curve, Models, Statistical, Databases, Factual, Area Under Curve, Prescription Drugs, Data Mining, Databases, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.